← FDA Drug Approvals (Drugs@FDA)

REXULTI

NDA · New Drug Application · Sponsor: OTSUKA · Approved 2015-07-10

Drug application

FDA Application #

NDA205422

Application type

New Drug Application

Brand name

REXULTI

Generic name

BREXPIPRAZOLE

Active ingredients

BREXPIPRAZOLE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

OTSUKA

Manufacturer

Otsuka America Pharmaceutical, Inc.

First approval

2015-07-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown